Bill

Bill > A3655


NJ A3655

NJ A3655
Extends "Epinephrine Access and Emergency Treatment Act" to include administration of epinephrine auto-injector devices by individuals in possession of devices pursuant to personal prescriptions.


summary

Introduced
01/13/2026
In Committee
01/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026-2027 Regular Session

Bill Summary

This bill revises the provisions of the "Epinephrine Access and Emergency Treatment Act" to allow any person who is in possession of an epinephrine auto-injector device pursuant to a valid prescription that was issued to the person, or to a minor child of the person, to administer the auto-injector device to any individual who appears to be suffering from anaphylaxis or any other serious condition that is treatable with epinephrine. The person would not be subject to civil liability for administering the device in good faith and without fee. Currently, the "Epinephrine Access and Emergency Treatment Act" permits any person to obtain, administer, maintain, and dispose of epinephrine auto-injector devices upon completing an educational program approved by the Commissioner of Health. However, current law does not explicitly allow individuals in possession of a device pursuant to a prescription issued to that person or a minor child of the person to administer the device to another individual in an emergency. It is the sponsor's belief that extending the scope of the "Epinephrine Access and Emergency Treatment Act" in this way will help promote access to this life-saving medication and encourage individuals in possession of the devices to administer them in emergency situations.

AI Summary

This bill expands the "Epinephrine Access and Emergency Treatment Act" to allow individuals who possess an epinephrine auto-injector device, prescribed to them or their minor child, to administer it to someone experiencing anaphylaxis or another serious condition treatable with epinephrine, even if that person is not the patient for whom the prescription was written. Anaphylaxis is a severe, potentially life-threatening allergic reaction. The bill clarifies that these individuals, acting in good faith and without charge, will be protected from civil liability for administering the device, thereby aiming to increase access to this life-saving medication in emergencies.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Introduced, Referred to Assembly Health Committee (on 01/13/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...